| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.170.3.1131 |
| P698 | PubMed publication ID | 12538667 |
| P2093 | author name string | Keiko Ozato | |
| Tomohiko Tamura | |||
| Hideki Tsujimura | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 1131-1135 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells | |
| P478 | volume | 170 |
| Q36188887 | A STATus report on DC development |
| Q40342539 | A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes |
| Q35104157 | A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages |
| Q33992579 | A reporter mouse reveals lineage-specific and heterogeneous expression of IRF8 during lymphoid and myeloid cell differentiation |
| Q41155777 | A subset of human plasmacytoid dendritic cells expresses CD8α upon exposure to herpes simplex virus type 1. |
| Q33967201 | Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1. |
| Q84899447 | Are mouse models of human mycobacterial diseases relevant? Genetics says: 'yes!' |
| Q36722275 | Batf3 and Id2 have a synergistic effect on Irf8-directed classical CD8α+ dendritic cell development. |
| Q34760844 | Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo |
| Q47412930 | Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation |
| Q36106506 | CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis |
| Q35209897 | CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites |
| Q34093092 | CX 3 CR1 + CD8α + dendritic cells are a steady-state population related to plasmacytoid dendritic cells |
| Q37273216 | Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function. |
| Q38215842 | Complementary diversification of dendritic cells and innate lymphoid cells. |
| Q53849724 | CpG-activated Thy1.2+ dendritic cells protect against lethal Listeria monocytogenes infection. |
| Q36399276 | CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens |
| Q28591631 | Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development |
| Q38341202 | Cystatin C is a disease-associated protein subject to multiple regulation |
| Q37095249 | Defective development of splenic and epidermal CD4+ dendritic cells in mice deficient for IFN regulatory factor-2. |
| Q40188534 | Defective inflammatory monocyte development in IRF8-deficient mice abrogates migration to the West Nile virus-infected brain. |
| Q98735442 | Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead |
| Q41610273 | Dendritic cell development: a choose-your-own-adventure story |
| Q41872369 | Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow |
| Q92181801 | Determination of antiviral action of long non-coding RNA loc107051710 during infectious bursal disease virus infection due to enhancement of interferon production |
| Q28293931 | Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B |
| Q37350374 | Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments |
| Q35017560 | Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8. |
| Q27022894 | Diversification of dendritic cell subsets: Emerging roles for STAT proteins |
| Q38934112 | Epigenetic program and transcription factor circuitry of dendritic cell development |
| Q36637528 | Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus |
| Q36666804 | Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation |
| Q28119180 | Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8(K108E) mutation |
| Q85179313 | Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccines |
| Q50125373 | Human dendritic cell subsets: an update |
| Q35122396 | IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation |
| Q34105647 | IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice |
| Q36394965 | IRF family proteins and type I interferon induction in dendritic cells |
| Q34077874 | IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells |
| Q85337479 | IRF8 inhibits C/EBPα activity to restrain mononuclear phagocyte progenitors from differentiating into neutrophils |
| Q35106002 | IRF8 mutations and human dendritic-cell immunodeficiency |
| Q35847894 | Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. |
| Q35848777 | Ikaros is required for plasmacytoid dendritic cell differentiation |
| Q38181331 | Innate immunity to Toxoplasma gondii infection |
| Q37102729 | Interferon and cytokine responses to SARS-coronavirus infection |
| Q36132841 | Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells |
| Q33951982 | Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis |
| Q35828776 | Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors |
| Q37342272 | Interferons: signaling, antiviral and viral evasion |
| Q34819713 | Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria |
| Q35978570 | Loss of IRF8 Inhibits the Growth of Diffuse Large B-cell Lymphoma |
| Q28476629 | Lymphoid organ-resident dendritic cells exhibit unique transcriptional fingerprints based on subset and site |
| Q39146128 | Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease |
| Q37802420 | Mechanisms regulating dendritic cell specification and development |
| Q26862947 | Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity |
| Q37407893 | Molecular characterization of human plasmacytoid dendritic cells. |
| Q27011850 | Molecular control of monocyte development |
| Q37789820 | Molecular mechanisms for plasmacytoid dendritic cell function and development |
| Q52726024 | Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer. |
| Q41612737 | Ocular Behcet's disease is associated with aberrant methylation of interferon regulatory factor 8 (IRF8) in monocyte-derived dendritic cells |
| Q34533117 | PU.1 is essential for CD11c expression in CD8(+)/CD8(-) lymphoid and monocyte-derived dendritic cells during GM-CSF or FLT3L-induced differentiation |
| Q37019332 | Plasmacytoid dendritic cells in HIV infection |
| Q37769441 | Plasmacytoid dendritic cells in antiviral immunity and autoimmunity |
| Q24558695 | Plasmacytoid dendritic cells: linking innate and adaptive immunity |
| Q37222231 | Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. |
| Q26777199 | Predominant Role of Plasmacytoid Dendritic Cells in Stimulating Systemic Autoimmunity |
| Q36231531 | Production of type I interferons: plasmacytoid dendritic cells and beyond |
| Q26864537 | Pulmonary dendritic cell development and antigen acquisition |
| Q24616755 | Rare lung diseases III: pulmonary Langerhans' cell histiocytosis |
| Q33964547 | Recent advances in the genetics of systemic lupus erythematosus |
| Q38004975 | Regulation of T helper cell differentiation by interferon regulatory factor family members |
| Q38058240 | Regulation of TLR7/9 signaling in plasmacytoid dendritic cells |
| Q24293755 | Regulation of immunity and oncogenesis by the IRF transcription factor family |
| Q38370092 | Regulation of myelopoiesis by the transcription factor IRF8. |
| Q37690000 | Regulation of plasmacytoid dendritic cell development. |
| Q36028191 | Roles of interferon-regulatory factors in T-helper-cell differentiation |
| Q34055580 | Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells |
| Q34359204 | Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells |
| Q34591334 | Steady-state and inflammatory dendritic-cell development |
| Q36730742 | Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma |
| Q36445813 | The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse |
| Q24647527 | The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development |
| Q29618424 | The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting |
| Q38293022 | The development and function of lung-resident macrophages and dendritic cells. |
| Q37401277 | The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. |
| Q36346824 | The interferon response circuit: induction and suppression by pathogenic viruses |
| Q37050929 | The role of the vascular dendritic cell network in atherosclerosis |
| Q40352693 | The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8 |
| Q28593689 | The small ubiquitin-like modifier-deconjugating enzyme sentrin-specific peptidase 1 switches IFN regulatory factor 8 from a repressor to an activator during macrophage activation |
| Q33881880 | Tissue-specific positive feedback requirements for production of type I interferon following virus infection |
| Q33683729 | Toll-like receptor 9-induced type I IFN protects mice from experimental colitis |
| Q24645273 | Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development |
| Q24616336 | Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation |
| Q89997630 | Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses |
| Q36819003 | Transcription factors in the control of dendritic cell life cycle |
| Q34249412 | Transcriptional programming of the dendritic cell network |
| Q35927398 | Transcriptional regulation of dendritic cell diversity |
| Q34810257 | Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy |
| Q36072422 | Type I interferons (alpha/beta) in immunity and autoimmunity |
| Q79777420 | Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells |
| Q34517731 | miR-22 controls Irf8 mRNA abundance and murine dendritic cell development |
Search more.